$522 Million is the total value of SABBY MANAGEMENT, LLC's 106 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 71.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Sell | BIOGEN INCcall | $67,630,000 | -28.9% | 2,762 | -17.7% | 12.96% | -8.7% | |
| Sell | BIOGEN INCput | $49,560,000 | -25.9% | 2,024 | -14.2% | 9.50% | -4.9% | |
| Sell | MODERNA INCput | $39,072,000 | +32.4% | 3,740 | -10.4% | 7.49% | +70.0% | |
| Sell | ISHARES RUSSELL 2000put | $32,115,000 | -2.0% | 1,638 | -25.1% | 6.16% | +25.8% | |
| MRNA | Sell | MODERNA INC | $12,119,000 | +40.4% | 116,000 | -4.9% | 2.32% | +80.4% |
| Sell | ISHARES RUSSELL 2000call | $8,999,000 | -42.8% | 459 | -56.3% | 1.72% | -26.5% | |
| Sell | MODERNA INCcall | $7,480,000 | -3.2% | 716 | -34.4% | 1.43% | +24.4% | |
| Sell | CEL-SCI CORPput | $6,417,000 | -35.3% | 5,503 | -29.2% | 1.23% | -16.9% | |
| Sell | CARDIFF ONCOLOGYput | $5,163,000 | -6.4% | 2,870 | -26.2% | 0.99% | +20.3% | |
| NMRD | Sell | NEMAURA MEDICAL INC | $1,864,000 | -14.5% | 494,297 | -19.5% | 0.36% | +9.8% |
| Sell | CEL-SCI CORPcall | $1,482,000 | -74.8% | 1,271 | -72.4% | 0.28% | -67.6% | |
| ITCI | Sell | INTRA-CELLULAR THERAPIES | $1,113,000 | -62.3% | 35,000 | -69.6% | 0.21% | -51.7% |
| Sell | BRAINSTORM CELL THERAPEUTICSput | $1,073,000 | -85.7% | 2,371 | -46.6% | 0.21% | -81.6% | |
| ODT | Sell | ODONATE THERAPEUTICS INC | $921,000 | -12.4% | 47,945 | -38.8% | 0.18% | +12.7% |
| NRBO | Sell | NEUROBO PHARMACEUTICALS | $748,000 | -27.1% | 142,400 | -22.0% | 0.14% | -6.5% |
| RMTI | Sell | ROCKWELL MEDICAL INC | $618,000 | -83.9% | 611,992 | -83.0% | 0.12% | -79.4% |
| EMBI | Sell | EMERALD BIOSCIENCE INC | $579,000 | -8.5% | 14,480,000 | -3.1% | 0.11% | +18.1% |
| Sell | EVOKE PHARMA INCput | $289,000 | -59.4% | 1,120 | -26.3% | 0.06% | -48.1% | |
| PRFX | Sell | PAINREFORM LTD | $275,000 | -86.6% | 61,606 | -86.2% | 0.05% | -82.7% |
| PHAS | Sell | PHASEBIO PHARMACEUTICALS INC | $218,000 | -21.9% | 65,000 | -18.2% | 0.04% | 0.0% |
| GOVX | Sell | GEOVAX LABS INC | $191,000 | -75.1% | 56,380 | -76.6% | 0.04% | -67.8% |
| Sell | POLARITYTE INCput | $163,000 | -67.5% | 2,392 | -50.3% | 0.03% | -58.7% | |
| Sell | EMAGIN CORPput | $137,000 | -8.1% | 829 | -29.3% | 0.03% | +18.2% | |
| RKDA | Sell | ARCADIA BIOSCIENCES INC | $82,000 | -89.4% | 32,503 | -88.2% | 0.02% | -86.1% |
| Sell | ADAMIS PHARMACEUTICALS CORPput | $76,000 | -37.7% | 1,562 | -0.2% | 0.02% | -16.7% | |
| NSPR | Sell | INSPIREMD INC | $60,000 | -22.1% | 174,813 | -28.3% | 0.01% | +9.1% |
| BIOL | Sell | BIOLASE INC | $26,000 | -71.7% | 62,748 | -81.2% | 0.01% | -64.3% |
| Sell | CALADRIUS BIOSCIENCESput | $16,000 | -94.5% | 110 | -93.3% | 0.00% | -93.2% | |
| Exit | PARETEUM CORPput | $0 | – | -299 | -100.0% | -0.00% | – | |
| Exit | LIPOCINE INC NEWput | $0 | – | -150 | -100.0% | -0.00% | – | |
| BKYI | Exit | BIO KEY INTL INC | $0 | – | -100,000 | -100.0% | -0.01% | – |
| Exit | ZOMEDICA PHARMACEUTICALS | $0 | – | -470,548 | -100.0% | -0.01% | – | |
| Exit | NABRIVA THERAPEUTICS PLCput | $0 | – | -958 | -100.0% | -0.01% | – | |
| BNTC | Exit | BENITEC BIOPHARMA INC | $0 | – | -11,863 | -100.0% | -0.01% | – |
| CTXR | Exit | CITIUS PHARMACEUTICALS | $0 | – | -88,711 | -100.0% | -0.01% | – |
| MDGSW | Exit | MEDIGUS LTD*w | $0 | – | -544,940 | -100.0% | -0.01% | – |
| Exit | LM FUNDING AMERICA INC | $0 | – | -147,304 | -100.0% | -0.01% | – | |
| Exit | BAUDAX BIO INCput | $0 | – | -410 | -100.0% | -0.02% | – | |
| Exit | CURIS INCcall | $0 | – | -1,131 | -100.0% | -0.02% | – | |
| Exit | LIPOCINE INC NEWcall | $0 | – | -941 | -100.0% | -0.02% | – | |
| Exit | NABRIVA THERAPEUTICS PLC | $0 | – | -268,109 | -100.0% | -0.02% | – | |
| Exit | ACTINIUM PHARMACEUTICALSput | $0 | – | -164 | -100.0% | -0.02% | – | |
| CLBS | Exit | CALADRIUS BIOSCIENCES | $0 | – | -96,001 | -100.0% | -0.03% | – |
| Exit | CATABASIS PHARMScall | $0 | – | -277 | -100.0% | -0.03% | – | |
| HEPA | Exit | HEPION PHARMACEUTICALS | $0 | – | -57,309 | -100.0% | -0.03% | – |
| ALT | Exit | ALTIMMUNE INC | $0 | – | -13,800 | -100.0% | -0.03% | – |
| SNCA | Exit | SENECA BIOPHARMA INC | $0 | – | -393,411 | -100.0% | -0.03% | – |
| Exit | GENOCEA BIOSCIENCES INCcall | $0 | – | -1,032 | -100.0% | -0.04% | – | |
| MKGI | Exit | MONAKER GROUP INC | $0 | – | -134,585 | -100.0% | -0.04% | – |
| SCPH | Exit | SCPHARMACEUTICALS INC | $0 | – | -42,407 | -100.0% | -0.05% | – |
| USEG | Exit | U S ENERGY CORP WY | $0 | – | -66,504 | -100.0% | -0.05% | – |
| Exit | CYTOKINETICS INCcall | $0 | – | -157 | -100.0% | -0.05% | – | |
| PAVMZ | Exit | PAVMED INC*w | $0 | – | -436,973 | -100.0% | -0.05% | – |
| XLV | Exit | SELECT SECTOR SPDR TRetf | $0 | – | -4,000 | -100.0% | -0.06% | – |
| ADTX | Exit | ADITX THERAPEUTICS INC | $0 | – | -224,971 | -100.0% | -0.07% | – |
| CYCC | Exit | CYCLACEL PHARMACEUTICALS | $0 | – | -125,578 | -100.0% | -0.07% | – |
| Exit | ODONATE THERAPEUTICS INCput | $0 | – | -354 | -100.0% | -0.07% | – | |
| Exit | CATABASIS PHARMSput | $0 | – | -891 | -100.0% | -0.08% | – | |
| Exit | SAREPTA THERAPEUTICcall | $0 | – | -44 | -100.0% | -0.09% | – | |
| LPCN | Exit | LIPOCINE INC NEW | $0 | – | -443,469 | -100.0% | -0.09% | – |
| PSTI | Exit | PLURISTEM THERAPEUTICS | $0 | – | -59,730 | -100.0% | -0.09% | – |
| BBI | Exit | BRICKELL BIOTECH INC | $0 | – | -721,887 | -100.0% | -0.10% | – |
| Exit | AKERS BIOSCIENCES INC | $0 | – | -299,913 | -100.0% | -0.10% | – | |
| GNCA | Exit | GENOCEA BIOSCIENCES INC | $0 | – | -312,666 | -100.0% | -0.11% | – |
| TTNP | Exit | TITAN PHARMACEUTICALS | $0 | – | -4,856,723 | -100.0% | -0.12% | – |
| PDSB | Exit | PDS BIOTECHNOLOGY CORP | $0 | – | -419,836 | -100.0% | -0.15% | – |
| Exit | ALTIMMUNE INCput | $0 | – | -761 | -100.0% | -0.15% | – | |
| Exit | AURINIA PHARMACEUTICALScall | $0 | – | -704 | -100.0% | -0.16% | – | |
| Exit | SAREPTA THERAPEUTICput | $0 | – | -76 | -100.0% | -0.16% | – | |
| OLB | Exit | OLB GROUP INC | $0 | – | -311,010 | -100.0% | -0.17% | – |
| FGEN | Exit | FIBROGEN INC | $0 | – | -29,654 | -100.0% | -0.18% | – |
| CRIS | Exit | CURIS INC | $0 | – | -1,179,600 | -100.0% | -0.21% | – |
| IBB | Exit | ISHARES NASDAQ BIOTECHetf | $0 | – | -11,372 | -100.0% | -0.23% | – |
| CNTG | Exit | CENTOGENE N V | $0 | – | -182,275 | -100.0% | -0.26% | – |
| EYEN | Exit | EYENOVIA INC | $0 | – | -608,720 | -100.0% | -0.28% | – |
| BLU | Exit | BELLUS HEALTH INC NEW | $0 | – | -880,400 | -100.0% | -0.30% | – |
| Exit | CELLDEX THERAPEUTICcall | $0 | – | -1,392 | -100.0% | -0.31% | – | |
| NVCN | Exit | NEOVASC INC | $0 | – | -1,009,406 | -100.0% | -0.32% | – |
| SHIP | Exit | SEANERGY MARITIME | $0 | – | -5,349,284 | -100.0% | -0.36% | – |
| COCP | Exit | COCRYSTAL PHARMA INC | $0 | – | -2,667,293 | -100.0% | -0.37% | – |
| VXX | Exit | BARCLAYS BANK PLCetf | $0 | – | -100,000 | -100.0% | -0.37% | – |
| CKPT | Exit | CHECKPOINT THERAPEUTICS | $0 | – | -931,240 | -100.0% | -0.37% | – |
| Exit | ISHARES NASDAQ BIOTECHcall | $0 | – | -189 | -100.0% | -0.38% | – | |
| Exit | TRILLIUM THERAPEUTICS INCcall | $0 | – | -1,860 | -100.0% | -0.40% | – | |
| CIDM | Exit | CINEDIGM CORP | $0 | – | -4,875,949 | -100.0% | -0.41% | – |
| Exit | ASTRAZENECA PLCcall | $0 | – | -521 | -100.0% | -0.43% | – | |
| Exit | SPI ENERGY CO LTD | $0 | – | -425,762 | -100.0% | -0.46% | – | |
| ACAD | Exit | ACADIA PHARMACEUTICALS INC | $0 | – | -99,921 | -100.0% | -0.62% | – |
| IMMU | Exit | IMMUNOMEDICS INC | $0 | – | -50,000 | -100.0% | -0.64% | – |
| Exit | FIBROGEN INCput | $0 | – | -1,418 | -100.0% | -0.87% | – | |
| Exit | PLURISTEM THERAPEUTICSput | $0 | – | -5,984 | -100.0% | -0.94% | – | |
| Exit | PFIZER INCcall | $0 | – | -1,817 | -100.0% | -1.00% | – | |
| SRNE | Exit | SORRENTO THERAPEUTICS | $0 | – | -606,298 | -100.0% | -1.01% | – |
| Exit | SELECT SECTOR SPDR TRcall | $0 | – | -834 | -100.0% | -1.31% | – | |
| Exit | ISHARES NASDAQ BIOTECHput | $0 | – | -923 | -100.0% | -1.87% | – | |
| Exit | TESLA INCput | $0 | – | -435 | -100.0% | -3.20% | – | |
| Exit | SPDR S&P 500call | $0 | – | -867 | -100.0% | -4.34% | – | |
| Exit | TESLA INCcall | $0 | – | -850 | -100.0% | -5.44% | – | |
| Exit | SELECT SECTOR SPDR TRput | $0 | – | -4,634 | -100.0% | -7.30% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SPDR S&P 500 ETF TRUST UNIT | 37 | Q3 2023 | 49.1% |
| ISHARES TR | 35 | Q3 2023 | 52.2% |
| SPDR S&P BIOTECHNOLOGY | 32 | Q3 2022 | 12.8% |
| AMARIN CORP PLC | 30 | Q4 2021 | 2.0% |
| BIOGEN INC | 24 | Q1 2021 | 26.2% |
| SAREPTA THERAPEUTICS INC | 24 | Q3 2020 | 4.6% |
| BIOGEN INC | 23 | Q1 2021 | 13.7% |
| SAREPTA THERAPEUTICS INC | 22 | Q3 2020 | 6.2% |
| BRAINSTORM CELL THERAPEUTICS INC | 21 | Q3 2023 | 1.6% |
| VERTEX PHARMACEUTICALS INC | 20 | Q1 2018 | 12.6% |
View SABBY MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| AGM GROUP HOLDINGS, INC. | January 10, 2023 | 627,936 | 2.6% |
| Bit Digital, Inc | January 10, 2023 | 3,166,917 | 3.8% |
| Cingulate Inc. | January 10, 2023 | 10 | 5.0% |
| Context Therapeutics Inc. | January 10, 2023 | 796,706 | 5.0% |
| HeartBeam, Inc. | January 10, 2023 | 271,788 | 3.4% |
| PharmaCyte Biotech, Inc. | January 10, 2023 | 934,456 | 5.0% |
| Rebus Holdings, Inc.Sold out | January 10, 2023 | 0 | 0.0% |
| TANTECH HOLDINGS LTD | January 10, 2023 | 41,500 | 0.6% |
| Quanergy Systems, Inc. | January 04, 2023 | 936,905 | 5.8% |
| TuanChe Ltd | January 04, 2023 | 2,384,713 | 10.0% |
View SABBY MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-03 |
| SC 13G | 2024-01-03 |
| SC 13G | 2024-01-03 |
| SC 13G | 2024-01-03 |
View SABBY MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.